News | Enterprise Imaging | May 25, 2017

Konica Minolta will highlight cross-department enterprise imaging and workflow solution at SIIM 2017

May 25, 2017 — At the 2017 annual meeting of the Society for Imaging Informatics in Medicine (SIIM), June 1-3 in Pittsburgh, Konica Minolta Healthcare Americas Inc. will showcase advanced specialty viewing capabilities of the Exa Enterprise Imaging platform. The platform facilitates the viewing of large medical imaging files, such as 3-D mammography and nuclear medicine, quickly and efficiently on existing workstations throughout the enterprise. With the Exa diagnostic quality Zero Footprint Universal Viewer, clinicians can view these images and more from any modality and any vendor. Exa delivers relevant priors from the picture archiving and communication system (PACS) or vendor neutral archive (VNA), including 3-D breast tomosynthesis, quickly and securely.

Exa delivers a cross-department enterprise imaging and workflow solution. Through server-side rendering, the platform provides fast access to large files without the need for prefetching. The Exa Universal Viewer and VNA enable viewing of DICOM and non-DICOM images from any device. Additionally, Exa provides cybersecurity with no data transferred to or stored on workstations.

By using Exa, any modality breast image — 3-D breast tomosynthesis, digital mammography, ultrasound and magnetic resonance imaging (MRI) — can be viewed by a radiologist on any 5MP workstation with an internet connection. Existing workstations can be repurposed with the diagnostic Exa Universal Viewer for sites that implement 3-D breast tomosynthesis.

Nuclear medicine specialists can also utilize the Exa Universal Viewer to read positron emission tomography (PET)/computed tomography (CT) studies from any location. Exa supports Fusion, MPR, MIP and full measurement tools for these studies.

For more information: www.konicaminolta.com/medicalusa


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
Subscribe Now